US › Healthcare

Journey Medical Corp (DERM)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$4.47+3.95%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$18.5M

Revenue YoY

+23.3%

Net profit

$-312,000

EPS

$-0.01

EPS estimate

$-0.01

Net margin

-1.7%

EPS came in at -0.01 against a street estimate of -0.01 — a beat of 0.0%.

Key statistics

Market cap

$121.4M

Forward P/E

18.6

P/B

4.09

Book value

$1.16

EPS (TTM)

$-0.22

52-week high

$9.55

52-week low

$4.25

50-day MA

$6.34

200-day MA

$6.59

Beta

1.15

Analyst view

Analysts rate Journey Medical Corp a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $13.75.

Shareholding

Insiders

31.75%

Institutions

48.67%

Largest institutional holders

Fund	Stake
Wasatch Advisors LP	10.13%
TANG CAPITAL MANAGEMENT LLC	5.70%
Vanguard Capital Management, LLC	2.39%
Punch & Associates Inv Mgmt Inc	1.90%
Pale Fire Capital SE	1.87%
Opaleye Management Inc	1.24%
Summit Financial LLC	1.23%
Jane Street Group LLC	1.13%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Journey Medical Corp — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.